Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Plus Therapeutics (PSTV) Return on Equity (2016 - 2025)

Plus Therapeutics has reported Return on Equity over the past 15 years, most recently at 0.03% for Q4 2025.

  • Quarterly Return on Equity fell 6.0% to 0.03% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.03% through Dec 2025, down 6.0% year-over-year, with the annual reading at 0.06% for FY2025, 4.0% up from the prior year.
  • Return on Equity was 0.03% for Q4 2025 at Plus Therapeutics, down from 0.03% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.04% in Q1 2024 and troughed at 0.21% in Q4 2023.
  • The 5-year median for Return on Equity is 0.01% (2021), against an average of 0.02%.
  • Year-over-year, Return on Equity dropped -19bps in 2023 and then rose 23bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.01% in 2021, then crashed by -214bps to 0.02% in 2022, then tumbled by -818bps to 0.21% in 2023, then soared by 110bps to 0.02% in 2024, then plummeted by -268bps to 0.03% in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Return on Equity are 0.03% (Q4 2025), 0.03% (Q3 2025), and 0.01% (Q2 2025).